CINQAERO conc perf 100 mg/10ml flac 10 ml
7680663400039
CH-66340
R03DX08
03.04.5.
Reimbursement limitations:
CINQAERO
À la suite de la garantie de prise en charge par l’assureur maladie après consultation …
1 / 3
google
Details
- Product number
- 6634001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- reslizumabum 100 mg, saccharum, natrii acetas trihydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 1.41 mg.
Articles (1)
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.41 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 633.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2018
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66340
- Drug name
- Cinqaero, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- R03DX08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/11/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CINQAERO conc perf 100 mg/10ml flac 10 ml
- Description (DE)
- CINQAERO Inf Konz 100 mg/10ml Durchstf 10 ml
- Market launch
- 09/11/2017
- Narcotic (BTM)
- No